Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.7K
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

141
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
141
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

11.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

942
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
942
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Apoptosis-inducing effect and structural basis of Polygonatum cyrtonema lectin and chemical modification properties on its mannose-binding sites.

BMB reports·2008
Same author

The catalytic intermediate stabilized by a "down" active site loop for diaminopimelate decarboxylase from Helicobacter pylori. Enzymatic characterization with crystal structure analysis.

The Journal of biological chemistry·2008
Same author

Monitoring prostate thermal therapy with diffusion-weighted MRI.

Magnetic resonance in medicine·2008
Same author

Removal of ammonia nitrogen in wastewater by microwave radiation.

Journal of hazardous materials·2008
Same author

[Three-dimensional anatomical position of rotatory center in cervical rotatory and local manipulation].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University·2008
Same author

Dysregulation of CREB binding protein triggers thrombin-induced proliferation of vascular smooth muscle cells.

Molecular and cellular biochemistry·2008

Related Experiment Video

Updated: Jan 8, 2026

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.5K

MOCT: A Multi-Class Oblique Tree Algorithm for Synergistic Drug Combination Prediction.

Zhikai Lin, Jing Chen, Lianlian Wu

    IEEE Transactions on Computational Biology and Bioinformatics
    |December 18, 2025
    PubMed
    Summary

    This study introduces a novel clustering-based oblique decision tree (MOCT) algorithm for drug combination prediction. MOCT effectively handles class imbalance and enhances model interpretability for biological and medical applications.

    More Related Videos

    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    19.4K
    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.5K

    Related Experiment Videos

    Last Updated: Jan 8, 2026

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
    07:51

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

    Published on: May 21, 2018

    12.5K
    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    19.4K
    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.5K

    Area of Science:

    • Computational biology
    • Machine learning
    • Pharmacology

    Background:

    • Machine learning models are increasingly used for drug combination prediction.
    • Class imbalance and lack of interpretability are significant challenges in current predictive models.
    • Existing methods struggle to address these issues effectively in complex biological datasets.

    Purpose of the Study:

    • To propose a novel clustering-based oblique decision tree (MOCT) algorithm.
    • To extract interpretable knowledge from multi-class datasets, specifically for drug combination prediction.
    • To address the limitations of traditional methods in handling class imbalance and ensuring model interpretability.

    Main Methods:

    • Developed a clustering-based oblique decision tree (MOCT) algorithm.
    • Implemented a hierarchical clustering approach to group samples by class.
    • Generated feature subspaces for data splitting and node creation, optimizing for interpretability and conciseness.
    • MOCT grows only one non-leaf node per layer, ensuring a compact tree structure.

    Main Results:

    • The MOCT algorithm demonstrated superior performance compared to other methods in drug combination prediction tasks.
    • The proposed method effectively handled class imbalance issues inherent in biological datasets.
    • Experimental results from three cell lines showed enhanced model interpretability, crucial for biological and medical experts.

    Conclusions:

    • The MOCT algorithm offers a robust solution for drug combination prediction, particularly in scenarios with class imbalance.
    • The interpretability of MOCT facilitates better understanding and trust in predictive models for clinical applications.
    • This approach advances the application of machine learning in precision medicine by providing interpretable and accurate predictions.